The Role of microRNAs in Medulloblastoma

REFERENCES

• US Cancer Statistics Working Group. United States Cancer Statistics: 1999–2005 Incidence and Mortality Web-based Report. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2009.
   Google Scholar
• Linet MS, Ries LA, Smith MA, Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst. 1999;91:1051–1058.
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Câncer (Brasil). Coordenação de Prevenção e Vigilância de Câncer. Câncer da criança e adolescente no Brasil: dados dos registros de base populacional e de mortalidade. Rio de Janeiro, BRAZIL: Instituto Nacional de Câncer (INCA); 2008.
   Google Scholar
• McNeil DE, Cote TR, Clegg L, Rorke LB. Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance epidemiology and end results. Med Pediatr Oncol. 2002;39:190–194.
   PubMedGoogle Scholar
• Rossi A, Caracciolo V, Russo G, Medulloblastoma: from molecular pathology to therapy. Clin Cancer Res. 2008;14:971–976.
   PubMed Web of Science ®Google Scholar
• Zeltzer PM, Boyett JM, Finlay JL, Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol. 1999;17:832–845.
   PubMed Web of Science ®Google Scholar
• Louis DN, Ohgaki H, Wiestler OD, The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109.
   PubMed Web of Science ®Google Scholar
• Mueller S, Chang S. Pediatric brain tumors: current treatment strategies and future therapeutic approaches. Neurotherapeutics. 2009;6:570–586.
   PubMedGoogle Scholar
• Bourdeaut F, Miquel C, Alapetite C, Medulloblastomas: update on a heterogeneous disease. Curr Opin Oncol. 2011;23:630–637.
   PubMedGoogle Scholar
• Hottinger AF, Khakoo Y. Neurooncology of familial cancer syndromes. J Child Neurol. 2009;24:1526–1535.
   PubMed Web of Science ®Google Scholar
• Levanat S, Gorlin RJ, Fallet S, A two-hit model for developmental defects in Gorlin syndrome. Nat Genet. 1996;12:85–87.
   Web of Science ®Google Scholar
• Taylor MD, Liu L, Raffel C, Mutations in SUFU predispose to medulloblastoma. Nat Genet. 2002;31:306–310.
   PubMed Web of Science ®Google Scholar
• Cho YJ, Tsherniak A, Tamayo P, Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol. 2011;29:1424–1430.
   PubMed Web of Science ®Google Scholar
• Ellison DW, Dalton J, Kocak M, Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol. 2011;121:381–396.
   PubMed Web of Science ®Google Scholar
• Northcott PA, Shih DJ, Remke M, Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol. 2012;123:615–626.
   PubMed Web of Science ®Google Scholar
• Parsons DW, Li M, Zhang X, The genetic landscape of the childhood cancer medulloblastoma. Science. 2011;331:435–439.
   PubMed Web of Science ®Google Scholar
• Kool M, Korshunov A, Remke M, Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas. Acta Neuropathol. 2012;123:473–484.
   PubMed Web of Science ®Google Scholar
• Almeida MI, Reis RM, Calin GA. MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res. 2011;717:1–8.
   PubMed Web of Science ®Google Scholar
• Bartel DP, Chen CZ. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet. 2004;5:396–400.
   PubMed Web of Science ®Google Scholar
• Chiang HR, Schoenfeld LW, Ruby JG, Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev. 2010;24:992–1009.
   PubMed Web of Science ®Google Scholar
• Van Wynsberghe PM, Chan SP, Slack FJ, Pasquinelli AE. Analysis of microRNA expression and function. Methods Cell Biol. 2011;106:219–252.
   PubMedGoogle Scholar
• Sevignani C, Calin GA, Siracusa LD, Croce CM. Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome. 2006;17:189–202.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Kanai A. Systems biology reveals microRNA-mediated gene regulation. Front Genet. 2011;2:article 29.
   Google Scholar
• Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199–227.
   PubMed Web of Science ®Google Scholar
• Santarpia L, Nicoloso M, Calin GA. MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype. Endocr Relat Cancer. 2010;17:F51–F75.
   PubMedGoogle Scholar
• Palmero EI, de Campos SG, Campos M, Mechanisms and role of microRNA deregulation in cancer onset and progression. Genet Mol Biol. 2011;34:363–370.
   PubMed Web of Science ®Google Scholar
• Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302:1–12.
   PubMed Web of Science ®Google Scholar
• Calin GA, Ferracin M, Cimmino A, A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005;353:1793–1801.
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–866.
   PubMed Web of Science ®Google Scholar
• Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell. 2008;133:217–222.
   PubMed Web of Science ®Google Scholar
• O'Donnell KA, Wentzel EA, Zeller KI, c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005;435:839–843.
   PubMed Web of Science ®Google Scholar
• Tarasov V, Jung P, Verdoodt B, Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle. 2007;6:1586–1593.
   PubMed Web of Science ®Google Scholar
• Calin GA, Sevignani C, Dumitru CD, Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 2004;101:2999–3004.
   PubMed Web of Science ®Google Scholar
• Zhang L, Huang J, Yang N, microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA. 2006;103:9136–9141.
   PubMed Web of Science ®Google Scholar
• Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2008;36:D154–D158.
   PubMed Web of Science ®Google Scholar
• Pierson J, Hostager B, Fan R, Vibhakar R. Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neurooncol. 2008;90:1–7.
   PubMed Web of Science ®Google Scholar
• Li KK, Pang JC, Ching AK, miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum Pathol. 2009;40:1234–1243.
   PubMed Web of Science ®Google Scholar
• Garzia L, Andolfo I, Cusanelli E, MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS One. 2009;4:e4998.
   PubMed Web of Science ®Google Scholar
• Grunder E, D'Ambrosio R, Fiaschetti G, MicroRNA-21 suppression impedes medulloblastoma cell migration. Eur J Cancer. 2011;47:2479–2490.
   PubMed Web of Science ®Google Scholar
• Ferretti E, De Smaele E, Miele E, Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. EMBO J. 2008;27:2616–2627.
   PubMed Web of Science ®Google Scholar
• Ferretti E, De Smaele E, Po A, MicroRNA profiling in human medulloblastoma. Int J Cancer. 2009;124:568–577.
   PubMed Web of Science ®Google Scholar
• Bai AH, Milde T, Remke M, MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. Acta Neuropathol. 2012;123:529–538.
   PubMed Web of Science ®Google Scholar
• Uziel T, Karginov FV, Xie S, The miR-17∼92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc Natl Acad Sci USA. 2009;106:2812–2817.
   PubMed Web of Science ®Google Scholar
• He L, Thomson JM, Hemann MT, A microRNA polycistron as a potential human oncogene. Nature. 2005;435:828–833.
   PubMed Web of Science ®Google Scholar
• Northcott PA, Fernandez LA, Hagan JP, The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res. 2009;69:3249–3255.
   PubMed Web of Science ®Google Scholar
• Lu Y, Ryan SL, Elliott DJ, Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma. PLoS One. 2009;4:e6159.
   PubMedGoogle Scholar
• Gokhale A, Kunder R, Goel A, Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. J Cancer Res Ther. 2010;6:521–529.
   PubMed Web of Science ®Google Scholar
• Liu W, Gong YH, Chao TF, Identification of differentially expressed microRNAs by microarray: a possible role for microRNAs gene in medulloblastomas. Chin Med J (Engl). 2009;122:2405–2411.
   PubMedGoogle Scholar
• Genovesi LA, Carter KW, Gottardo NG, Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells. PLoS One. 2011;6:e23935.
   PubMedGoogle Scholar
• Birks DK, Barton VN, Donson AM, Survey of MicroRNA expression in pediatric brain tumors. Pediatr Blood Cancer. 2011;56:211–216.
   Google Scholar
• Sredni ST, Huang CC, Bonaldo Mde F, Tomita T. MicroRNA expression profiling for molecular classification of pediatric brain tumors. Pediatr Blood Cancer. 2011;57:183–184.
   PubMedGoogle Scholar
• Lv SQ, Kim YH, Giulio F, Genetic alterations in microRNAs in medulloblastomas. Brain Pathol. 2012;22:230–239.
   PubMedGoogle Scholar
• Rossbach M. Small non-coding RNAs as novel therapeutics. Curr Mol Med. 2010;10:361–368.
   PubMed Web of Science ®Google Scholar
• Nana-Sinkam SP, Croce CM. Clinical applications for microRNAs in cancer. Clin Pharmacol Ther. 2013;93:98–104.
   PubMed Web of Science ®Google Scholar
• Wu J, Qian J, Li C, miR-129 regulates cell proliferation by downregulating Cdk6 expression. Cell Cycle. 2010;9:1809–1818.
   PubMed Web of Science ®Google Scholar
• Laneve P, Di Marcotullio L, Gioia U, The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. Proc Natl Acad Sci USA. 2007;104:7957–7962.
   PubMed Web of Science ®Google Scholar
• Venkataraman S, Alimova I, Fan R, MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence. PLoS One. 2010;5:e10748.
   PubMedGoogle Scholar
• Li Y, Guessous F, Zhang Y, MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009;69:7569–7576.
   PubMed Web of Science ®Google Scholar
• Guessous F, Zhang Y, Kofman A, microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle. 2010;9:1031–1036.
   PubMed Web of Science ®Google Scholar
• Weeraratne SD, Amani V, Neiss A, miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma. Neuro Oncol. 2011;13:165–175.
   PubMed Web of Science ®Google Scholar
• de Antonellis P, Medaglia C, Cusanelli E, MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133 +tumor-propagating cells and supports neural differentiation in medulloblastoma. PLoS One. 2011;6:e24584.
   PubMed Web of Science ®Google Scholar